Harmonic's current share price is a bargain per the price multiple model. Despite a positive profit outlook, growth isn't fully factored into the price. A low beta suggests it may not reach industry peer level soon. Financial health should also be considered.
Harmonic Inc's high P/S ratio is justified by anticipated robust future revenue. Confidence in this revenue sustains the share price, assuming accurate analyst predictions.
U.S. stock futures were trading within a tight range during Monday's evening deals after major benchmark averages posted moderate gains as investors look toward a fresh deluge of quarterly earnings results throughout the week. Yum China Holdings$百勝中國(YUMC.US)$fell 2.8% after the company reported Q2 EPS of $0.47 versus $0.46 expected, with revenues of $2.65 billion versus $2.72B expected. Harmonic$諧波(HLIT.US)$shed 13.7% after report...
Upgrades •$Marqeta(MQ.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $15 •$西北天然氣(NWN.US)$: BofA Securities Upgrades to Neutral from Underperform - PT $53 (from $51) •$奧的斯(OTIS.US)$: Barclays Upgrades to Overweight from Equalweight - PT $82 (from $80) •$Snowflake(SNOW.US)$: Rosenblatt Upgrades to Buy from Neutral - PT $255 (from $325) Downgrades •$伊頓(ETN.US)$: Barclays Downgrades to Underweight from Eq...
Gainers: •$Belite Bio(BLTE.US)$+17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1) •$Atkore(ATKR.US)$+12.11% (earnings reports) •$AST SpaceMobile(ASTS.US)$+9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing) •$諧波(HLIT.US)$+7.56% (earnings reports) •$The Chemours(CC.US)$+7.2% ...
諧波股票討論區
Yum China Holdings $百勝中國(YUMC.US)$ fell 2.8% after the company reported Q2 EPS of $0.47 versus $0.46 expected, with revenues of $2.65 billion versus $2.72B expected.
Harmonic $諧波(HLIT.US)$ shed 13.7% after report...
5年來資產負債率變化不大,從55.3%微降到54.3%,應收賬款近期變化不大,但是存貨增漲非常快2021年從0.35億增長到0.71億,2022年從0.71億增長到1.21億,增幅均大幅超過當期淨利潤,不過比例還算正常,2022年短期借款增加到1.2億,應該是爲了應對存貨增多後的資金短缺。
5年來長期負債下降很多,2022年僅剩0.11億,說明管理層認爲資金短缺應該是短期現象。
5年來經營淨額大比例超過投資淨額,股東盈餘較多。
目前市盈率53,不知道高增長是否可持續,再觀察兩份季報再做判斷。
• $Marqeta(MQ.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $15
• $西北天然氣(NWN.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $53 (from $51)
• $奧的斯(OTIS.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $82 (from $80)
• $Snowflake(SNOW.US)$ : Rosenblatt Upgrades to Buy from Neutral - PT $255 (from $325)
Downgrades
• $伊頓(ETN.US)$ : Barclays Downgrades to Underweight from Eq...
• $Belite Bio(BLTE.US)$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore(ATKR.US)$ +12.11% (earnings reports)
• $AST SpaceMobile(ASTS.US)$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $諧波(HLIT.US)$ +7.56% (earnings reports)
• $The Chemours(CC.US)$ +7.2% ...
• $Bank First(BFC.US)$ : Piper Sandler Upgrades to Overweight From Neutral - PT $84 (from $76)
• $E2open Parent(ETWO.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $12
• $諧波(HLIT.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $11
• $MarketAxess(MKTX.US)$ : Compass Point Upgrades to Neutral from Sell - PT $275 (from $300)
• $PBF Energy(PBF.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $30 (from $20)
• $山脈資源(RRC.US)$ : Piper S...
暫無評論